Poliovirus, long COVID, mental health stigma: Top Q&As of 2022
Click Here to Manage Email Alerts
Throughout the year, Healio has conducted exclusive interviews to learn more about new research on clinical conditions as well as other health care updates and how they will impact primary care practices.
The most popular Q&A for primary care providers was a conversation with Alanna E. Levine, MD, about the discovery of poliovirus in sewage systems in New York. Others included research on the science behind long COVID, frequently asked questions about COVID-19 vaccines in infants and toddlers, and how stigma prevents some physicians from accessing mental health services.
Read the top Q&As for PCPs from 2022 below:
Q&A: Poliovirus discovery in NY ‘hard to believe’
Last week, health officials in New York State announced the detection of poliovirus in sewage in Orange and Rockland counties, where only around 60% of young children are caught up on their polio vaccinations. Read more.
Q&A: Updated CDC guidance has implications for children, schools
The CDC has updated its guidance for COVID-19, including loosening recommendations that will affect the way students return to classrooms in the upcoming school year. Read more.
Q&A: Frequently asked questions about COVID-19 vaccines for infants, toddlers
COVID-19 vaccines are now available for children as young as age 6 months in the United States. Read more.
Q&A: SARS-CoV-2 can trigger autoantibody reactivity lasting months after infection
SARS-CoV-2 infection, even in asymptomatic cases, can lead to a broad autoantibody response that lasts beyond recovery from infection, according to findings published in the Journal of Translational Medicine. Read more.
Q&A: Even mild COVID-19 cases may accelerate aging process
A recent study published in Frontiers in Genetics found that even mild cases of COVID-19 may speed up the body’s rate of aging, although receiving a COVID-19 vaccine might reverse these effects. Read more.
Q&A: The science behind long COVID symptoms
New research seems to help explain the biology behind long COVID symptoms like brain fog and increased anxiety and depression. Read more.
Q&A: Mpox in children
The CDC released clinical considerations for mpox in children and adolescents after announcing the first two pediatric cases in the United States. Read more.
Q&A: What to know about parechovirus, subject of CDC alert
This past summer, the CDC issued a health advisory alerting clinicians that parechovirus, a common childhood pathogen, was circulating in the United States. Read more.
Q&A: RSV surge hits US children, stretching hospital capacity
Common childhood infections have returned following an interruption caused by the COVID-19 pandemic, including respiratory syncytial virus, which has caused a recent surge in the United States. Read more.
Q&A: Physicians call for changes to medical licensing applications
Research has shown that questions about physicians’ mental health on state licensing and credentialing applications often discourage them from seeking mental health treatment. Read more.